[1]郑光明,孙建华,宋秋月.结直肠癌组织中锌指蛋白139（ZNF139）的表达及临床意义研究[J].现代检验医学杂志,2022,37(04):107-111+168.[doi:10.3969/j.issn.1671-7414.2022.04.021]
　ZHENG Guang-ming,SUN Jian-hua,SONG Qiu-yue.Expression and Clinical Significance of Zinc Finger Protein 139 (ZNF139) in Colorectal Cancer[J].Journal of Modern Laboratory Medicine,2022,37(04):107-111+168.[doi:10.3969/j.issn.1671-7414.2022.04.021]
点击复制

结直肠癌组织中锌指蛋白139（ZNF139）的表达及临床意义研究()
分享到：

《现代检验医学杂志》[ISSN:/CN:]

卷:
第37卷
期数:
2022年04期
页码:
107-111+168
栏目:
论著
出版日期:
2022-07-15

文章信息/Info

Title:
Expression and Clinical Significance of Zinc Finger Protein 139 (ZNF139) in Colorectal Cancer
文章编号:
1671-7414（2022）04-107-06
作者:
郑光明; 孙建华; 宋秋月
恩施土家族苗族自治州中心医院，湖北恩施 445000
Author(s):
ZHENG Guang-ming;  SUN Jian-hua;  SONG Qiu-yue
Enshi Tujia and Miao Autonomous Prefecture Central Hospital, Hubei Enshi 445000,China
关键词:
锌指蛋白139; 结直肠癌; 实时荧光定量逆转录聚合酶链反应; 免疫组织化学染色
分类号:
R735.3；R730.43
DOI:
10.3969/j.issn.1671-7414.2022.04.021
文献标志码:
A
摘要:
目的 探究锌指蛋白139（zinc finger protein 139，ZNF139）在结直肠癌(colorectal cancer) 组织中的表达及与临床病理参数及预后的关系。方法 选取2012 年5 月～ 2014 年6 月就诊于恩施土家族苗族自治州中心医院行手术治疗的67 例结直肠癌患者的临床病理资料及癌组织、癌旁组织和正常黏膜组织进行研究。采用实时荧光定量逆转录聚合酶链反应（RT-PCR）和免疫组织化学法染色检测ZNF139 mRNA 及蛋白在结直肠癌组织中的表达情况，分析其与结直肠癌患者临床病理因素的关系；采用K-M 生存曲线分析ZNF139 表达对预后的影响；采用COX 回归模型分析影响结直肠癌患者预后的风险因素。结果 结直肠癌病灶组织中ZNF139 mRNA（0.651±0.130）表达水平明显高于癌旁组织（0.217±0.070）和正常组织（0.201±0.052），差异有统计学意义（t=24.060, 24.947, 均P=0.001）。结直肠癌组织中ZNF139 蛋白阳性率（52.24%）明显高于癌旁组织（28.36%）和正常黏膜组织（19.40%），差异均有统计学意义（χ2 = 7.941，15.711；P =0.005，0.000）。结直肠癌组织中ZNF139 mRNA 及蛋白表达与肿瘤分化程度、浸润程度、TNM 分期和有无淋巴结转移密切相关（t=4.447 ～ 10.964，χ2 =16.613 ～ 35.850，均P ＜ 0.01）。ZNF139 阴性表达组患者5 年总体生存率为75.0%，优于阳性组患者的51.4%（Log-rank χ2 =3.391，P=0.047）。ZNF139 表达（HR：2.249，95%CI：1.359 ～ 3.712，P=0.003），临床TNM分期（HR：2.016，95%CI：1.230 ～ 3.327，P=0.006）和淋巴结转移（HR：2.125，95%CI：1.302 ～ 3.469，P=0.002）是影响结直肠癌患者总体预后的独立危险因素。结论 ZNF139 在结直肠癌组织中高（阳性）表达，与结直肠癌的分化、浸润、TNM 分期和有无淋巴结转移密切相关，是影响结直肠癌患者预后的独立危险因素之一，可作为临床诊断及评估预后的参考指标。
Abstract:
Objective To investigate the relationship between the expression of zinc finger protein 139 (ZNF139) in colorectal cancer tissues and the pathological parameters and prognosis of patients. Methods The clinicopathological data of 67 patients with colorectal cancer who received surgical treatment in Enshi Tujia and Miao Autonomous Prefecture Central Hospital from May 2012 to June 2014, as well as cancer tissue, para-cancer tissue and normal mucosal tissue, were selected for the study. Realtime fluorescence quantitative reverse transcription polymerase chain reaction (RT-PCR) and immunohistochemical staining were used to detect the expression of ZNF139 mRNA and protein in colorectal cancer tissues, and analyze its relationship with the clinicopathological factors of colorectal cancer patients. K-M survival curve was used to analyze the effect of ZNF139 expression on prognosis. Cox regression model was used to analyze the risk factors affecting the prognosis of colorectal cancer patients. Results The expression level of ZNF139 mRNA in colorectal cancer foci (0.651±0.130) was significantly higher than that in adjacent tissues (0.217±0.070) and normal tissues (0.201±0.052)，the differences were statistically significant(t=24.060, 24.947, all P =0.001). The positive rate of ZNF139 protein in colorectal cancer tissues (52.24%) was significantly higher than that in adjacent tissues (28.36%) and normal mucosa tissues (19.40%)，the differences were statistically significant (χ2=7.941, 15.71, all P ＜ 0.01). The expression of ZNF139 mRNA and protein in colorectal cancer was closely related to the degree of tumor differentiation, invasion, TNM stage and lymph node metastasis (t=4.447 ～ 10.964，χ2 =16.613 ～ 35.850，all P ＜ 0.01). The 5-year overall survival rate of patients with negative expression of ZNF139 was 75.0%, which was better than that of patients with positive expression (51.4%) (Log-rank χ2 =3.391, P =0.047). ZNF139 expression (HR: 2.249, 95%CI: 1.359 ～ 3.712, P =0.003), clinical TNM stage (HR: 2.016, 95%CI: 1.223 ～ 3.327, P =0.006), lymph node metastasis (HR: 2.125, 95%CI: 1.302 ～ 3.469, P =0.002) was an independent risk factor affecting the overall prognosis of colorectal cancer patients. Conclusion The high (positive) expression of ZNF139 in colorectal cancer tissues was closely related to the differentiation, infiltration, TNM stage and lymph node metastasis of colorectal cancer.It is an independent risk factor affecting the prognosis of colorectal cancer patients and can be used as a reference index for clinical diagnosis and prognosis evaluation.

参考文献/References:

[1] 田耀文, 霍婷婷, 王东旭, 等. 结直肠癌同时性肝外转移相关临床病理因素分析[J]. 中华肿瘤防治杂志,2018, 25(2): 135-139. TIAN Yaowen, HUO Tingting, WANG Dongxu, et al. Clinical and pathological analysis of simultaneous extrahepatic metastasis of colorectal [J]. Chinese Journal of Cancer Prevention and Treatment, 2018,25(2): 135-139.
[2] ZHENG Rongshou, ZENG Hongmei, ZHANG Siwei,et al. The epidemiology of colorectal cancer in China[ J]. Global Health Journal, 2018, 2(3):8-20.
[3] CAI Jing, LIU Wenfeng, WONG Chunwa, et al. Zincfinger antiviral protein acts as a tumor suppressor in colorectal cancer[J]. Oncogene, 2020, 39(37): 5995-6008.
[4] YAO Jie, QIAN Kaiyu, CHEN Chen, et al. ZNF139/circZNF139 promotes cell proliferation, migration and invasion via activation of PI3K/AKT pathway in bladder cancer[J].Aging (Albany NY),2020,12(10):9915-9934.
[5] 李世拥. 实用结直肠癌外科学[M]. 北京: 人民卫生出版社, 2012． LI Shiyong. Practical surgery of colorectal cancer [M].Beijing: People’s Medical Publishing House, 2012.
[6] 史敏, 郭晓波, 李思远, 等. 结直肠癌患者组织中K-ras 和BRAF 基因突变与不同病理特征的相关性分析[J]. 现代检验医学杂志,2018,33(3):27-30. SHI Min, GUO Xiaobo, LI Siyuan, et al. Correlation of K-ras and BRAF mutations with pathological features in patients with colorectal cancer [J]. Journal of Modern Laboratory Medicine,2018,33(3):27-30.
[7] QIU Lei, HU Xiaoyan, JING Qian, et al. Mechanism of cancer: Oncohistones in action[J]. Journal of Genetics and Genomics, 2018, 45(5): 227-236.
[8] NGUYEN L H, TRAN T T, NGUYEN T T. Overcharging of Zinc ion in Zinc finger protein structure is needed for DNA binding stability[J]. Biochemistry, 2020,59(13): 1378-1390.
[9] NOWACKA M, FERNANDES H, KILISZEK A, et al.Specific interaction of Zinc finger protein Com with RNA and the crystal structure of a self-complementary RNA duplex recognized by Com[J]. PLoS One, 2019,14(4): e0214481.
[10] 艾廉杰, 朴大勋. 结肠癌中相关锌指蛋白的研究进展[J]. 实用肿瘤学杂志,2018,32(6):567-570. AI Lianjie, PIAO Daxun. Research progress in Zinc finger proteins in colon cancer [J]. Practical Oncology Journal,2018,32(6):567-570.
[11] 李镠祎, 杨红健. 锌指蛋白调控乳腺癌增殖的研究进展[J]. 肿瘤学杂志, 2020, 26(11):991-994. LI Liuyi, YANG Hongjian. Research progress on Zinc finger protein regulating breast cancer proliferation [J].Journal of Chinese Oncology, 2020, 26(11):991-994.
[12] YE Qin, LIU Jiayang, XIE Ke. Zinc finger proteins and regulation of the hallmarks of cancer[J]. Histology and Histopathology, 2019, 34(10): 1097-1109.
[13] DEUTSCHMEYER V E, RICHTER A M. The ZAR1 protein in cancer; from epigenetic silencing to functional characterisation and epigenetic therapy of tumour suppressors[J]. Biochimica et Biophysica Acta-Reviews on Cancer, 2020, 1874(2): 188417.
[14] 常世川, 冉文华, 罗贤琴, 等. 非小细胞肺癌锌指蛋白217 的表达及其临床意义[J]. 肿瘤研究与临床,2019, 31(5):310-314. CHANG Shichuan, RAN Wenhua, LUO Xianqin, et al. Expression of Zinc finger protein 217 in non-small cell lung cancer and its clinical significance [J]. Cancer Research and Clinic, 2019, 31(5):310-314.
[15] 谢易, 李彬彬, 龚泰芳. 锌指蛋白ZNF139 抑制骨肉瘤细胞增殖和转移的机制研究[J]. 贵州医药, 2019,43(11):1688-1692. XIE Yi, LI Binbin, GONG Taifang. Study on the effect of tumor suppressor gene ZNF139 on proliferation and migration of osteosarcoma [J].Guizhou Medical Journal,2019,43(11):1688-1692.
[16] TAN Bibo, LI Yong, ZHAO Qun, et al. ZNF139 increases multidrug resistance in gastric cancer cells by inhibiting miR-185[J]. Bioscience Reports, 2018, 38(5):BSR20181023.
[17] NIE Hongfeng, MU Jixing, WANG Jinsheng, et al.MiR-195-5p regulates multi-drug resistance of gastric cancer cells via targeting ZNF139[J]. Oncology Reports, 2018, 40(3): 1370-1378.

相似文献/References:

[1]陈建国.结直肠癌患者FOLFOX化疗与GSTP1,XRCC1基因多态性的研究[J].现代检验医学杂志,2016,31(05):66.[doi:10.3969/j.issn.1671-7414.2016.05.017]
　CHEN Jian-guo.Relationship between FOLFOX Chemotherapy of Colorectal Cancer Patients and GSTP1,XRCC1 Gene Polymorphism[J].Journal of Modern Laboratory Medicine,2016,31(04):66.[doi:10.3969/j.issn.1671-7414.2016.05.017]
[2]周秋媛,王红莉,李虹,等.NRP-1和NRP-2在结直肠癌组织中的表达水平及临床意义[J].现代检验医学杂志,2016,31(06):85.[doi:10.3969/j.issn.1671-7414.2016.06.024]
　ZHOU Qiu-yuan,WANG Hong-li,LI Hong,et al.Serum NRP-1 and NRP-2 Expression in Colorectal Cancer Patients and Its Relationship with Clinical Pathology[J].Journal of Modern Laboratory Medicine,2016,31(04):85.[doi:10.3969/j.issn.1671-7414.2016.06.024]
[3]史 敏,郭晓波,李思远,等.结直肠癌患者组织中K-ras和BRAF基因突变与不同病理特征的相关性分析[J].现代检验医学杂志,2018,33(03):27.[doi:10.3969/j.issn.1671-7414.2018.03.009]
　SHI Min,GUO Xiao-bo,LI Si-yuan,et al.Correlation of K-ras and BRAF Mutations with Pathological Features in Patients with Colorectal Cancer[J].Journal of Modern Laboratory Medicine,2018,33(04):27.[doi:10.3969/j.issn.1671-7414.2018.03.009]
[4]井丰军,倪勇.结直肠癌患者外周血NLR与RDW的变化及临床意义[J].现代检验医学杂志,2018,33(03):99.[doi:10.3969/j.issn.1671-7414.2018.03.025]
　JING Feng-jun,NI Yong.Change and Significance of Neutrophil/Lymphocyte Ratio and Red Blood Cell Distribution Width of Peripheral Blood in the Colorectal Cancer[J].Journal of Modern Laboratory Medicine,2018,33(04):99.[doi:10.3969/j.issn.1671-7414.2018.03.025]
[5]滕祥云,王新梦,刘　维,等.中国汉族结直肠癌患者 UGT1A1*28基因多态性分析[J].现代检验医学杂志,2019,34(06):20.[doi:10.3969 ／ j.issn.1671-7414.2019.06.005]
　TENG Xiang-yun,WANG Xin-meng,LIU Wei,et al.Polymorphism of UGT1A1*28 Gene in Han Patients with Colorectal Cancer in China[J].Journal of Modern Laboratory Medicine,2019,34(04):20.[doi:10.3969 ／ j.issn.1671-7414.2019.06.005]
[6]陈 培,邓钦木,李丹丹.血浆Septin9 甲基化检测在结直肠癌中的诊断价值[J].现代检验医学杂志,2020,35(04):10.[doi:10.3969/j.issn.1671-7414.2020.04.003]
　CHEN Pei,DENG Qin-mu,LI Dan-dan.Diagnostic Value of Plasma Septin9 Methylation in Screening of Colorectal Cancer[J].Journal of Modern Laboratory Medicine,2020,35(04):10.[doi:10.3969/j.issn.1671-7414.2020.04.003]
[7]杨婕琳a,陈文婷b,胡晓利a.结直肠癌组织中硫氧还蛋白-1与硫氧还蛋白互作蛋白的表达及其临床意义[J].现代检验医学杂志,2021,36(06):22.[doi:10.3969/j.issn.1671-7414.2021.06.005]
　YANG Jie-lin,CHEN Wen-ting,HU Xiao-li.Expression and Clinical Significance of Thioredoxin-1 and Thioredoxin Interacting Protein in Colorectal Cancer[J].Journal of Modern Laboratory Medicine,2021,36(04):22.[doi:10.3969/j.issn.1671-7414.2021.06.005]
[8]马胜辉,崔雪琴,李建华,等.结直肠癌组织miR-485-5p，miR-1207-3p和miR-590-3p水平表达与临床病理特征及生存的相关性研究[J].现代检验医学杂志,2022,37(03):16.[doi:10.3969/j.issn.1671-7414.2022.03.004]
　MA Sheng-hui,CUI Xue-qin,LI Jian-hua,et al.Correlation of miR-485-5p, miR-1207-3p, miR-590-3p Level Expression and Clinicopathologic Characteristics and Survival in Colorectal Cancer Tissue[J].Journal of Modern Laboratory Medicine,2022,37(04):16.[doi:10.3969/j.issn.1671-7414.2022.03.004]
[9]胡道军,史文杰,孙 敏.LncRNA NEAT1/miR-23b-3p/KLF3 轴调控结直肠癌细胞的生物学功能研究[J].现代检验医学杂志,2022,37(04):1.[doi:10.3969/j.issn.1671-7414.2022.04.001]
　HU Dao-jun,SHI Wen-jie,SUN Min.LncRNA NEAT1/miR-23b-3p/ KLF3 Axis Regulates the Biological Function of Colorectal Cancer Cells[J].Journal of Modern Laboratory Medicine,2022,37(04):1.[doi:10.3969/j.issn.1671-7414.2022.04.001]
[10]冯 芬.结直肠癌组织中USP11 和PPP1CA 表达水平与临床病理的相关性研究[J].现代检验医学杂志,2022,37(04):43.[doi:10.3969/j.issn.1671-7414.2022.04.009]
　FENG Fen.Correlation between USP11 and PPP1CA Expression Levels and Clinicopathology in Colorectal Cancer Tissues[J].Journal of Modern Laboratory Medicine,2022,37(04):43.[doi:10.3969/j.issn.1671-7414.2022.04.009]

备注/Memo

备注/Memo:
作者简介：郑光明（1988-），男，主管护师，研究方向：普通外科学，E-mail：jocnp33@163.com。
更新日期/Last Update: 1900-01-01